Literature DB >> 21684746

7-Alkyl-N(2)-substituted-3-deazaguanines. Synthesis, DNA polymerase III inhibition and antibacterial activity.

Wei-Chu Xu1, George E Wright, Neal C Brown, Zheng-Yu Long, Cheng-Xin Zhi, Sofya Dvoskin, Joseph J Gambino, Marjorie H Barnes, Michelle M Butler.   

Abstract

Several 2-anilino- and 2-benzylamino-3-deaza-6-oxopurines [3-deazaguanines] and selected 8-methyl and 8-aza analogs have been synthesized. 7-Substituted N(2)-(3-ethyl-4-methylphenyl)-3-deazaguanines were potent and selective inhibitors of Gram+ bacterial DNA polymerase (pol) IIIC, and 7-substituted N(2)-(3,4-dichlorobenzyl)-3-deazaguanines were potent inhibitors of both pol IIIC and pol IIIE from Gram+ bacteria, but weakly inhibited pol IIIE from Gram- bacteria. Potent enzyme inhibitors in both classes inhibited the growth of Gram+ bacteria (MICs 2.5-10μg/ml), and were inactive against the Gram- organism Escherichia coli. Several derivatives had moderate protective activity in Staphylococcus aureus-infected mice.
Copyright © 2011 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21684746      PMCID: PMC3128661          DOI: 10.1016/j.bmcl.2011.05.093

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  10 in total

1.  Active site directed inhibitors of replication-specific bacterial DNA polymerases.

Authors:  George E Wright; Neal C Brown; Wei-Chu Xu; Zheng-Yu Long; Chengxin Zhi; Joseph J Gambino; Marjorie H Barnes; Michelle M Butler
Journal:  Bioorg Med Chem Lett       Date:  2005-02-01       Impact factor: 2.823

2.  6-Anilinouracil-based inhibitors of Bacillus subtilis DNA polymerase III: antipolymerase and antimicrobial structure-activity relationships based on substitution at uracil N3.

Authors:  P M Tarantino; C Zhi; J J Gambino; G E Wright; N C Brown
Journal:  J Med Chem       Date:  1999-06-03       Impact factor: 7.446

3.  Compilation, alignment, and phylogenetic relationships of DNA polymerases.

Authors:  D K Braithwaite; J Ito
Journal:  Nucleic Acids Res       Date:  1993-02-25       Impact factor: 16.971

4.  Synthesis and antiviral and enzymatic studies of certain 3-deazaguanines and their imidazolecarboxamide precursors.

Authors:  P D Cook; L B Allen; D G Streeter; J H Huffman; R W Sidwell; R K Robins
Journal:  J Med Chem       Date:  1978-12       Impact factor: 7.446

5.  Inhibitors of DNA polymerase III as novel antimicrobial agents against gram-positive eubacteria.

Authors:  P M Tarantino; C Zhi; G E Wright; N C Brown
Journal:  Antimicrob Agents Chemother       Date:  1999-08       Impact factor: 5.191

6.  Non-peptide angiotensin II receptor antagonists: synthesis and biological activity of a series of novel 4,5-dihydro-4-oxo-3H-imidazo[4,5-c]pyridine derivatives.

Authors:  W W Mederski; D Dorsch; H H Bokel; N Beier; I Lues; P Schelling
Journal:  J Med Chem       Date:  1994-05-27       Impact factor: 7.446

7.  Inhibition of Bacillus subtilis deoxyribonucleic acid polymerase III by phenylhydrazinopyrimidines. Demonstration of a drug-induced deoxyribonucleic acid-enzyme complex.

Authors:  J E Clements; J D'Ambrosio; N C Brown
Journal:  J Biol Chem       Date:  1975-01-25       Impact factor: 5.157

8.  Inhibitors of Bacillus subtilis DNA polymerase III. 6-Anilinouracils and 6-(alkylamino)uracils.

Authors:  G E Wright; N C Brown
Journal:  J Med Chem       Date:  1980-01       Impact factor: 7.446

9.  DNA polymerases of low-GC gram-positive eubacteria: identification of the replication-specific enzyme encoded by dnaE.

Authors:  Marjorie H Barnes; Shelley D Miller; Neal C Brown
Journal:  J Bacteriol       Date:  2002-07       Impact factor: 3.490

10.  Synthesis of substituted 6-anilinouracils and their inhibition of DNA polymerase IIIC and Gram-positive bacterial growth.

Authors:  Chengxin Zhi; Zheng-Yu Long; Joseph Gambino; Wei-Chu Xu; Neal C Brown; Marjorie Barnes; Michelle Butler; William LaMarr; George E Wright
Journal:  J Med Chem       Date:  2003-06-19       Impact factor: 7.446

  10 in total
  8 in total

1.  A novel agent effective against Clostridium difficile infection.

Authors:  Sofya Dvoskin; Wei-Chu Xu; Neal C Brown; Ivan B Yanachkov; Milka Yanachkova; George E Wright
Journal:  Antimicrob Agents Chemother       Date:  2011-12-27       Impact factor: 5.191

2.  Clostridium difficile DNA polymerase IIIC: basis for activity of antibacterial compounds.

Authors:  Andrea Torti; Andrea Lossani; Lida Savi; Federico Focher; George Edward Wright; Neal Curtis Brown; Wei-Chu Xu
Journal:  Curr Enzym Inhib       Date:  2011-10

Review 3.  DNA Replication in Mycobacterium tuberculosis.

Authors:  Zanele Ditse; Meindert H Lamers; Digby F Warner
Journal:  Microbiol Spectr       Date:  2017-03

4.  Biochemical and functional characterization of Plasmodium falciparum DNA polymerase δ.

Authors:  Jitlada Vasuvat; Atcha Montree; Sangduen Moonsom; Ubolsree Leartsakulpanich; Songsak Petmitr; Federico Focher; George E Wright; Porntip Chavalitshewinkoon-Petmitr
Journal:  Malar J       Date:  2016-02-24       Impact factor: 2.979

Review 5.  DNA replication proteins as potential targets for antimicrobials in drug-resistant bacterial pathogens.

Authors:  Erika van Eijk; Bert Wittekoek; Ed J Kuijper; Wiep Klaas Smits
Journal:  J Antimicrob Chemother       Date:  2017-05-01       Impact factor: 5.790

Review 6.  The Macromolecular Machines that Duplicate the Escherichia coli Chromosome as Targets for Drug Discovery.

Authors:  Jon M Kaguni
Journal:  Antibiotics (Basel)       Date:  2018-03-14

Review 7.  Targeting DNA Replication and Repair for the Development of Novel Therapeutics against Tuberculosis.

Authors:  Michael A Reiche; Digby F Warner; Valerie Mizrahi
Journal:  Front Mol Biosci       Date:  2017-11-14

Review 8.  Antibiotics in the clinical pipeline in October 2019.

Authors:  Mark S Butler; David L Paterson
Journal:  J Antibiot (Tokyo)       Date:  2020-03-10       Impact factor: 2.649

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.